JTC Team Announces Continuation of its Virtual Investor Spotlight Series with NASDAQ: AEZS, NASDAQ: CNSP, and NASDAQ: AREC
April 13, 2022 at 10:45 AM EDT
- Live video webcast events on Thursday, April 14 at 10 AM ET, 11:30 AM ET and 1 PM ET -
FRENCHTOWN, NJ / ACCESSWIRE / April 13, 2022 / JTC Team ("JTC"), a fully integrated corporate communications and investor relations firm, today announced the continuation of its Virtual Investor Spotlight Series to be held on Thursday, April 14, 2022. Access the full series of events here.
Thursday, April 14, 2022
As part of the virtual event, members of the Aeterna Zentaris management team will provide an overview of its growing pre-clinical pipeline to potentially address unmet medical needs across a number of indications, including neuromyelitis optica spectrum disorder (NMOSD), Parkinson's disease (PD), hypoparathyroidism and amyotrophic lateral sclerosis (ALS; Lou Gehrig's disease). Additionally, the Company will discuss its development progress on an oral prophylactic bacterial vaccine against SARS-CoV-2 (COVID-19) and Chlamydia trachomatis.
As part of the virtual event, members of the CNS Pharmaceuticals management team will be joined by leading Neuro-Oncologist, Samuel A. Goldlust, MD, Pitkin Chair in Neuro-Oncology, Medical Director of the Brain and Spine Institute, John Theurer Cancer Center and an investigator in the Company's global potentially pivotal study, to spotlight GBM, the unmet need and the work CNS Pharmaceuticals is doing to advance it's Berubicin clinical program.
As part of the virtual event, members from the American Resources management team will discuss the recent charge to the Defense Department from President Biden to consider the metals required to make the batteries used in clean energy technology as essential to national security under the Defense Production Act.
A live video webcast of the Spotlight series events will be available on virtualinvestorco.com. A webcast replay will be made available shortly after the conclusion of the live event and will be accessible for 90 days.
About JTC Team
JTC is a fully integrated corporate communications firm that is dedicated to helping you tell your story to the right audiences in order to build awareness. JTC has developed a reputation of excellence for executing on robust communication strategies that deliver results. The Company partners with both public and private companies across the Life Sciences and Technology industries to help raise awareness and build stakeholder value. For more information, please visit www.jtcir.com or connect with the company on Twitter and LinkedIn.
SOURCE: JTC Team, LLC
View source version on accesswire.com: